Nanjing University's own site covered the Nanjing Biomedicine Branch Centre and the founding of Eynos by Wang Yafeng, a biology PhD and postdoctoral researcher at Nanjing Drum Tower Hospital.
This page summarises a media report about Eynos. Quoted wording — including terms such as "breakthrough", "on par with", "first" or "unique" — is the original reporter's language and is not a performance claim by the company. Product performance is defined by the manual and the measured data. All products are for research use only (RUO) and are not intended for diagnostic or therapeutic use.
The piece is about the gap between a published result and a product: the months spent on formulation, stability and batch documentation that no paper records.
Eynos is described as an example of a team that stayed close to its own research question — immune cell separation — instead of broadening into a general reagent catalogue.
The full report is published in Chinese: 中文原文. This page is an English summary prepared by Eynos.
Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.